121 related articles for article (PubMed ID: 2438054)
1. Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor.
Koh CS; Paterson PY
Cell Immunol; 1987 Jun; 107(1):52-63. PubMed ID: 2438054
[TBL] [Abstract][Full Text] [Related]
2. Role of the clotting system in the pathogenesis of neuroimmunologic disease.
Paterson PY; Koh CS; Kwaan HC
Fed Proc; 1987 Jan; 46(1):91-6. PubMed ID: 2433164
[TBL] [Abstract][Full Text] [Related]
3. Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease.
Koh CS; Gausas J; Paterson PY
J Neuroimmunol; 1993 Sep; 47(2):141-5. PubMed ID: 8370766
[TBL] [Abstract][Full Text] [Related]
4. Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats.
Inoue A; Koh CS; Shimada K; Yanagisawa N; Yoshimura K
J Neuroimmunol; 1996 Dec; 71(1-2):131-7. PubMed ID: 8982112
[TBL] [Abstract][Full Text] [Related]
5. Concordance and localization of maximal vascular permeability change and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis.
Koh CS; Gausas J; Paterson PY
J Neuroimmunol; 1992 May; 38(1-2):85-93. PubMed ID: 1577954
[TBL] [Abstract][Full Text] [Related]
6. Neurovascular fibrinolytic activity in normal Lewis rats and rats with cell-transferred experimental allergic encephalomyelitis.
Koh CS; Kwaan HC; Paterson PY
J Neuroimmunol; 1990 Aug; 28(3):189-200. PubMed ID: 2373760
[TBL] [Abstract][Full Text] [Related]
7. Suppression of experimental allergic encephalomyelitis in Lewis rats treated with myelin basic protein-liposome complexes: clinical, histopathological, and cell-mediated immunity correlates.
Strejan GH; Percy DH; St Louis J
Cell Immunol; 1984 Mar; 84(1):171-84. PubMed ID: 6199120
[TBL] [Abstract][Full Text] [Related]
8. Effect of treatment with glutaraldehyde-fixed myelin basic protein-liposomes on active induction and passive transfer of experimental allergic encephalomyelitis in Lewis rats.
Strejan GH; Gilbert JJ; St Louis J
Cell Immunol; 1988 Oct; 116(1):250-6. PubMed ID: 2458844
[TBL] [Abstract][Full Text] [Related]
9. Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis.
Chelmicka-Schorr E; Kwasniewski MN; Wollmann RL
J Neuroimmunol; 1992 Mar; 37(1-2):99-103. PubMed ID: 1548379
[TBL] [Abstract][Full Text] [Related]
10. Experimental allergic encephalomyelitis: clinical disease and enhanced cellular transfer in the absence of lymphocyte proliferative responses against syngeneic MBP.
Hunter S
Cell Immunol; 1986 Jan; 97(1):204-9. PubMed ID: 2427218
[TBL] [Abstract][Full Text] [Related]
11. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.
Bolton C; Allsopp G; Cuzner ML
Clin Exp Immunol; 1982 Jan; 47(1):127-32. PubMed ID: 6178543
[TBL] [Abstract][Full Text] [Related]
12. The acquisition of encephalitogenicity after sensitized cells are conditioned with myelin basic protein or concanavalin A.
Levine S; Abreu SL; Sowinski R
Cell Immunol; 1985 Feb; 90(2):599-604. PubMed ID: 2578332
[TBL] [Abstract][Full Text] [Related]
13. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.
Stohl W; Gonatas NK
J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523
[TBL] [Abstract][Full Text] [Related]
14. The role of plasminogen activator in ovulation.
Akazawa K; Matsuo O; Kosugi T; Mihara H; Mori N
Acta Physiol Lat Am; 1983; 33(2):105-10. PubMed ID: 6422700
[TBL] [Abstract][Full Text] [Related]
15. Observations on the effects of protease inhibitors on the suppression of experimental allergic encephalomyelitis.
Smith ME; Amaducci LA
Neurochem Res; 1982 May; 7(5):541-54. PubMed ID: 6750429
[TBL] [Abstract][Full Text] [Related]
16. Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes.
Mannie MD; Paterson PY; U'Prichard DC; Flouret G
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5515-9. PubMed ID: 3875098
[TBL] [Abstract][Full Text] [Related]
17. Suppression of experimental allergic encephalomyelitis in Lewis rats by administration of gangliosides.
Shimada K; Koh CS; Uemura K; Yanagisawa N
Cell Immunol; 1994 Mar; 154(1):231-9. PubMed ID: 7509729
[TBL] [Abstract][Full Text] [Related]
18. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis.
Swierkosz JE; Swanborg RH
J Immunol; 1975 Sep; 115(3):631-3. PubMed ID: 50370
[TBL] [Abstract][Full Text] [Related]
19. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A.
Panitch HS; McFarlin DE
J Immunol; 1977 Sep; 119(3):1134-7. PubMed ID: 302272
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
